Enzalutamide Versus Bicalutamide in Castration-Resistant Prostate Cancer: The STRIVE Trial. Penson DF, Armstrong AJ, Concepcion R, Agarwal N, Olsson C, Karsh L, Dunshee C, Wang F, Wu K, Krivoshik A, Phung D, Higano CS (2016) J Clin Oncol 34: 2098-106 PIM kinase inhibitor AZD1208 for treatment of MYC-driven prostate cancer. Kirschner AN, Wang J, van der Meer R, Anderson PD, Franco-Coronel OE, Kushner MH, Everett JH, Hameed O, Keeton EK, Ahdesmaki M, Grosskurth SE, Huszar D, Abdulkadir SA (2015) J Natl Cancer Inst 107: Relationship of adenosine 3',5'-cyclic monophosphate and guanosine 3',5'-cyclic monophosphate to growth of dimethylbenz(a)anthracene-induced mammary tumors in rats. Matusik RJ, Hilf R (1976) J Natl Cancer Inst 56: 659-61 Inhibition of transplantation tolerance by immune senescence is reversed by endocrine modulation. Zhao G, Moore DJ, Kim JI, Lee KM, O'Connor MR, Duff PE, Yang M, Lei J, Markmann JF, Deng S (2011) Sci Transl Med 3: 87ra52 Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension. Holla VR, Adas F, Imig JD, Zhao X, Price E, Olsen N, Kovacs WJ, Magnuson MA, Keeney DS, Breyer MD, Falck JR, Waterman MR, Capdevila JH (2001) Proc Natl Acad Sci U S A 98: 5211-6 The Role of the EGF Receptor in Sex Differences in Kidney Injury. Zhang MZ, Sasaki K, Li Y, Li Z, Pan Y, Jin GN, Wang Y, Niu A, Wang S, Fan X, Chen JC, Borza C, Yang H, Pozzi A, Fogo AB, Harris RC (2019) J Am Soc Nephrol 30: 1659-1673 NF-κB gene signature predicts prostate cancer progression. Jin R, Yi Y, Yull FE, Blackwell TS, Clark PE, Koyama T, Smith JA, Matusik RJ (2014) Cancer Res 74: 2763-72 The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growth. Jin RJ, Lho Y, Connelly L, Wang Y, Yu X, Saint Jean L, Case TC, Ellwood-Yen K, Sawyers CL, Bhowmick NA, Blackwell TS, Yull FE, Matusik RJ (2008) Cancer Res 68: 6762-9 Inhibition of NF-kappa B signaling restores responsiveness of castrate-resistant prostate cancer cells to anti-androgen treatment by decreasing androgen receptor-variant expression. Jin R, Yamashita H, Yu X, Wang J, Franco OE, Wang Y, Hayward SW, Matusik RJ (2015) Oncogene 34: 3700-10 Competition between the Brain and Testes under Selenium-Compromised Conditions: Insight into Sex Differences in Selenium Metabolism and Risk of Neurodevelopmental Disease. Pitts MW, Kremer PM, Hashimoto AC, Torres DJ, Byrns CN, Williams CS, Berry MJ (2015) J Neurosci 35: 15326-38 Activation of GRP/GRP-R signaling contributes to castration-resistant prostate cancer progression. Qiao J, Grabowska MM, Forestier-Roman IS, Mirosevich J, Case TC, Chung DH, Cates JM, Matusik RJ, Manning HC, Jin R (2016) Oncotarget 7: 61955-61969 Characterization and cloning of rat dorsal prostate mRNAs. Androgen regulation of two closely related abundant mRNAs. Dodd JG, Sheppard PC, Matusik RJ (1983) J Biol Chem 258: 10731-7 Activation of Wnt/β-catenin signaling in a subpopulation of murine prostate luminal epithelial cells induces high grade prostate intraepithelial neoplasia. Valkenburg KC, Yu X, De Marzo AM, Spiering TJ, Matusik RJ, Williams BO (2014) Prostate 74: 1506-20 NF-κB and androgen receptor variant 7 induce expression of SRD5A isoforms and confer 5ARI resistance. Austin DC, Strand DW, Love HL, Franco OE, Grabowska MM, Miller NL, Hameed O, Clark PE, Matusik RJ, Jin RJ, Hayward SW (2016) Prostate 76: 1004-18 Increases in testosterone levels and in copulatory behavior of male rhesus monkeys following treatment with human chorionic gonadotrophin. Herndon JG, Allen WC, Blakely RD (1980) Horm Behav 14: 337-47 Nrf1 and Nrf2 transcription factors regulate androgen receptor transactivation in prostate cancer cells. Schultz MA, Hagan SS, Datta A, Zhang Y, Freeman ML, Sikka SC, Abdel-Mageed AB, Mondal D (2014) PLoS One 9: e87204 Radiosensitization by enzalutamide for human prostate cancer is mediated through the DNA damage repair pathway. Sekhar KR, Wang J, Freeman ML, Kirschner AN (2019) PLoS One 14: e0214670 Androgen receptor inhibitor treatments: Cardiovascular adverse events and comorbidity considerations in patients with non-metastatic prostate cancer. Morgans AK, Shore N, Cope D, McNatty A, Moslehi J, Gomella L, Sartor O (2021) Urol Oncol 39: 52-62 A phase II study of lapatinib, a dual EGFR and HER-2 tyrosine kinase inhibitor, in patients with castration-resistant prostate cancer. Whang YE, Armstrong AJ, Rathmell WK, Godley PA, Kim WY, Pruthi RS, Wallen EM, Crane JM, Moore DT, Grigson G, Morris K, Watkins CP, George DJ (2013) Urol Oncol 31: 82-6 Effects of nonylphenol, 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene (p,p'-DDE), and pentachlorophenol on the adult female guinea pig reproductive tract. Danzo BJ, Shappell HW, Banerjee A, Hachey DL (2002) Reprod Toxicol 16: 29-43
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.